F
V. V. Rao et al.
Paper
Synthesis
The chemistry and drastic change in the reactivity of the
same substrates toward two similar yet different electro-
philic source is interesting to observe, especially the selec-
tivity towards hydration rather than iodocyclization by the
internal potential nucleophiles. More investigations into
such conversions will be done in the future.
HRMS (ESI): m/z [M + Na]+ calcd for C18H18INO4Na+: 462.0173; found:
462.0194.
N-[2-(4-Hydroxy-2-iodobutanoyl)phenyl]acetamide (2c)
Yield: 43.7 mg (63%, 0.126 mmol); yellow solid; mp 124–126 °C.
1H NMR (400 MHz, CDCl3): δ = 11.41 (s, 1 H), 8.76 (d, J = 8.5 Hz, 1 H),
7.93 (dd, J = 8.1, 1.3 Hz, 1 H), 7.62–7.54 (m, 1 H), 7.15–7.08 (m, 1 H),
5.76 (t, J = 7.1 Hz, 1 H), 3.88–3.74 (m, 2 H), 2.39–2.31 (m, 2 H), 2.25 (s,
3 H).
All reactions were performed using oven dried glassware under N2 at-
mosphere. Chemicals were purchased from Sigma Aldrich and used as
received, unless otherwise mentioned. The products were purified by
column chromatography on silica gel 60–120 mesh. Technical grade
solvents were used for chromatography and distilled prior to use.
NMR spectra were recorded in Fourier transform mode. The 1H NMR,
13C NMR, and 19F NMR spectra were recorded on a 300 MHz, 400 MHz,
and 500 MHz spectrophotometer using CDCl3 and TMS as the internal
standard. Standard abbreviations were used to describe the multiplic-
ities in the 1H NMR spectra; coupling constants are reported in Hz.
Low- and high-resolution mass spectra were recorded by an ion-trap
method and mass/charge (m/z) ratios are reported as values in atomic
mass units. All melting points are uncorrected.
13C NMR (126 MHz, CDCl3): δ = 198.75, 169.50, 142.07, 135.70,
130.21, 122.43, 121.29, 118.89, 61.42, 37.43, 25.65, 23.48.
HRMS (ESI): m/z [M + H – H2O]+ calcd for C12H13INO2+: 329.9985;
found: 329.9997.
Ethyl [4-Fluoro-2-(4-hydroxy-2-iodobutanoyl)phenyl]carbamate
(2e)
Yield: 50.6 mg (64%, 0.128 mmol); gram-scale yield: 1.077 g (54%, 2.7
mmol); yellow solid; mp 98–100 °C.
1H NMR (400 MHz, CDCl3): δ = 10.64 (s, 1 H), 8.54–8.46 (m, 1 H), 7.57
(dd, J = 9.4, 2.9 Hz, 1 H), 7.33–7.27 (m, 1 H), 5.63 (t, J = 7.1 Hz, 1 H),
4.23 (q, J = 7.1 Hz, 2 H), 3.87–3.72 (m, 2 H), 2.39–2.30 (m, 2 H), 1.33 (t,
J = 7.1 Hz, 3 H).
13C NMR (101 MHz, CDCl3): δ = 197.22 (s), 156.48 (d, J = 242.8 Hz),
153.88 (s), 138.74 (s), 122.70 (d, J = 22.1 Hz), 121.63 (d, J = 7.0 Hz),
119.48 (d, J = 5.6 Hz), 115.99 (d, J = 23.6 Hz), 61.50 (s), 61.35 (s), 37.32
(s), 23.16 (s), 14.49 (s).
α-Iodoketones 2a–j and 4a from Aminoalkynols 1a–j and Alkynol
3a; General Procedure
Aminoalkynol 1a–j or alkynol 3a (0.2 mmol) and Na2CO3 (64 mg, 0.6
mmol, 3 equiv) were added to THF maintained at 0 °C under N2. To the
above stirred solution, a 1 M solution of ICl in CH2Cl2 (97.5 mg, 0.6
mL, 0.6 mmol, 3 equiv) was slowly added dropwise and the reaction
was allowed to proceed till the starting material was consumed (30–
60 min). Once the reaction was complete, EtOAc was added to the re-
action mixture and the organic phase was washed with sat. aq
Na2S2O3 and then washed with H2O. The organic layer was separated
and dried (anhyd Na2SO4). The solvent was evaporated under vacuum
and the crude product was purified by silica gel column chromatogra-
phy using PE/EtOAc (7:3) mixture as eluent.
19F NMR (376 MHz, CDCl3): δ = –120.12.
HRMS (ESI): m/z [M + Na]+ calcd for C13H15INO4Na+: 417.9922; found:
417.9952.
Ethyl [4-Chloro-2-(4-hydroxy-2-iodobutanoyl)phenyl]carbamate
(2f)
Yield: 45.3 mg (55%, 0.11 mmol); yellow solid; mp 92–95 °C.
1H NMR (400 MHz, CDCl3): δ = 10.74 (s, 1 H), 8.51 (d, J = 9.1 Hz, 1 H),
7.84 (d, J = 2.3 Hz, 1 H), 7.51 (dd, J = 9.1, 2.3 Hz, 1 H), 5.65 (t, J = 7.1 Hz,
1 H), 4.23 (q, J = 7.1 Hz, 2 H), 3.89–3.73 (m, 2 H), 2.40–2.31 (m, 2 H),
1.33 (t, J = 7.1 Hz, 3 H).
13C NMR (101 MHz, CDCl3): δ = 197.23, 153.67, 141.07, 135.27,
129.60, 126.45, 121.23, 119.67, 61.59, 61.39, 37.30, 23.13, 14.48.
Ethyl [2-(4-Hydroxy-2-iodobutanoyl)phenyl]carbamate (2a)
Yield: 57.3 mg (76%, 0.152 mmol); gram-scale yield: 1.30 g (69%, 3.45
mmol); yellow solid; mp 82–84 °C.
1H NMR (500 MHz, CDCl3): δ = 10.90 (s, 1 H), 8.52 (dd, J = 8.6, 0.9 Hz, 1
H), 7.92 (dd, J = 8.1, 1.4 Hz, 1 H), 7.59–7.54 (m, 1 H), 7.08–7.03 (m, 1
H), 5.74 (t, J = 7.1 Hz, 1 H), 4.23 (q, J = 7.1 Hz, 2 H), 3.87–3.75 (m, 2 H),
2.38–2.32 (m, 2 H), 1.33 (t, J = 7.1 Hz, 3 H).
HRMS (ESI): m/z [M + Na]+ calcd for C13H15ClINO4Na+: 433.9626;
found: 433.9716.
13C NMR (126 MHz, CDCl3): δ = 198.21, 153.82, 142.62, 135.60,
130.32, 121.37, 119.71, 118.45, 61.48, 61.37, 37.46, 23.44, 14.51.
HRMS (ESI): m/z [M + Na]+ calcd for C13H16INO4Na+: 400.0016; found:
400.0056.
Ethyl [5-Chloro-2-(4-hydroxy-2-iodobutanoyl)phenyl]carbamate
(2g)
Yield: 49.4 mg (60%, 0.12 mmol); yellow oil.
1H NMR (400 MHz, CDCl3): δ = 10.99 (s, 1 H), 8.62 (d, J = 2.1 Hz, 1 H),
7.84 (d, J = 8.7 Hz, 1 H), 7.02 (dd, J = 8.7, 2.1 Hz, 1 H), 5.67 (t, J = 7.1 Hz,
1 H), 4.24 (q, J = 7.1 Hz, 2 H), 3.87–3.72 (m, 2 H), 2.38–2.30 (m, 2 H),
1.34 (t, J = 7.1 Hz, 3 H).
13C NMR (101 MHz, CDCl3): δ = 197.41, 153.55, 143.69, 142.01,
131.46, 121.64, 119.59, 116.55, 61.66, 61.39, 37.33, 23.25, 14.46.
Benzyl [2-(4-Hydroxy-2-iodobutanoyl)phenyl]carbamate (2b)
Yield: 62.4 mg (71%, 0.142 mmol); yellow solid; mp 78–80 °C.
1H NMR (500 MHz, CDCl3): δ = 11.00 (s, 1 H), 8.53 (d, J = 8.5 Hz, 1 H),
7.91 (dd, J = 8.1, 1.2 Hz, 1 H), 7.59–7.54 (m, 1 H), 7.45–7.30 (m, 5 H),
7.09–7.04 (m, 1 H), 5.73 (t, J = 7.1 Hz, 1 H), 5.22 (s, 2 H), 3.84–3.73 (m,
2 H), 2.36–2.30 (m, 2 H).
HRMS (ESI): m/z [M + Na]+ calcd for C13H15ClINO4Na+: 433.9626;
found: 433.9653.
13C NMR (126 MHz, CDCl3): δ = 198.20, 153.58, 142.41, 136.00,
135.60, 130.35, 128.60, 128.33, 121.57, 119.78, 118.56, 67.08, 61.47,
37.43, 23.39.
Ethyl [2-(4-Hydroxy-2-iodobutanoyl)-4-nitrophenyl]carbamate
(2h)
Yield: 44.8 mg (53%, 0.106 mmol); yellow solid; mp 116–118 °C.
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2017, 49, A–G